Gilead Sciences Announces Third Quarter 2020 Dividend
July 30 2020 - 4:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
company’s Board of Directors has declared a cash dividend of $0.68
per share of common stock for the third quarter of 2020. The
dividend is payable on September 29, 2020, to stockholders of
record at the close of business on September 15, 2020. Future
dividends will be subject to Board approval.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200730005986/en/
Investors Adam Levy, MBA,
Ph.D. (650) 574-3000
Douglas Maffei, Ph.D. (650) 574-3000
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024